![]() |
5th International AIDS Society Conference on HIV Pathogenesis and TreatmentCape Town - July 19 - 22, 2009 |
HIV-1 Vpr-MEDIATED ATR ACTIVATION AND G2 CELL-CYCLE ARREST INDUCE UP-REGULATION OF NKG2D LIGANDS AND ACTIVATE NK CELL-MEDIATED KILLING
IAS Conf HIV Pathog Treat 2009 Jul 19-22;5th: Abstract No. MOAA201
J. Richard, S. Sindhu, J.-P. Belzile, É.A. Cohen
Institut de Recherches Cliniques de Montréal, Laboratory of Human Retrovirology, Montreal, Canada
BACKGROUND: HIV-1 Vpr activates ATR signaling and promotes G2 cell-cycle arrest by engaging the DDB1-CUL4ADCAF1 E3 ubiquitin ligase. The biological significance of Vpr-mediated G2 arrest in HIV-1 pathogenesis is however not well understood. Interestingly, in the context of cells accumulating DNA damages, ATR activation was shown to upregulate cell-surface NKG2D activating receptor ligands and hence, stimulate NK cell cytotoxic activity. In this study, we examined whether HIV-1 Vpr could enhance expression of NKG2D ligands and modulate NK cell-mediated killing.
METHODS: Cell-surface expression of NKG2D ligands was determined by flow cytometry and susceptibility to NK cellmediated killing was evaluated by chromium release assay.
RESULTS: Expression of Vpr in several human cell lines, including HeLa and CEM NKR T cells, as well as in primary CD4+ T lymphocytes was found to induce an up-regulation of the NKG2D ligands MICB and ULBP2/3. This effect was not observed with Vpr (Q65R), a G2 arrest-defective mutant unable to engage the CUL4A4-DDB1DCAF1 E3 ligase, nor upon treatment of cells with caffeine, a non specific inhibitor of ATR, thus indicating that up-regulation of NKG2D ligands was likely dependent on Vpr-mediated ATR activation and G2 arrest. Importantly, CEM NKR T cells and primary human CD4+ T lymphocytes expressing Vpr, as a transgene or a transduced virion-associated protein, were found to strongly activate NK cell-mediated killing. The role of Vpr in the up-regulation of NKG2D ligands was also investigated in the context of HIV- 1-infected primary CD4+ T cells. Interestingly, we found that up-regulation of ULBP2 induced by HIV-1 infection was further accentuated by Vpr.
CONCLUSIONS: Our data reveal that Vpr-mediated ATR activation and G2 arrest modulate NK cell cytotoxic activity through an up-regulation of NKG2D ligands. This immuno-modulatory activity of HIV-1 Vpr may contribute to CD4+ T cell depletion as well as NK cell dysfunction due to sustained effector activation.2009-07-22
MOAA201
Oral Abstract Session: MOAA2 - Subversion of Immune Responses in HIV Infection
Copyright © 2009 - International AIDS Society (IAS). All information and content relating to the abstracts from the 5th International AIDS Society Conference on HIV Pathogenesis and Treatment, such as text, graphics, logos, button icons, images, audio clips, and software is protected by copyright. Permission is hereby granted for the non-commercial use or reproduction of the information on this web site, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, AIDS Walk of Orange County, and donations from users like you. Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. Permission is hereby granted for the non-commercial use or reproduction of the information herein, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.